At the highest dose, 96% of participants achieved at least 5% body weight reduction, and 36.2% achieved reductions of 25% or more
10.1177/0363546511428879 Am
6 The American College of Cardiology and American Heart Association consider both classes reasonable for patients who have diabetes with established CVD, but they do not comment on the use of these medications for primary prevention in patients at high risk of MACE
Not for human or animal use, diagnostics, or treatment, and must be handled by qualified professionals
Gupta V: Pleiotropic effects of incretins
106 page premium digital PDF guide Beautiful visuals, frameworks, scripts & checklists Roadmaps & tools for every decision Built for fast decisions when your body is changing Delivered by email after purchase The complete digital guide is delivered by email after purchase